Jing-Ping Liou

18PUBLICATIONS
13CO-AUTHORS
Haematological tumoursGene and molecular therapyMolecular targetsCheminformatics and quantitative structure-activity relationshipsProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jun 09, 2026
Dual SYK-HDAC Inhibitor Elicits Striking Efficacy against Acute Myeloid Leukemia: Rational Design, Synthesis, and Biological Evaluation.

|Jan 21, 2025
Repurposing Linezolid in Conjunction with Histone Deacetylase Inhibitor Access in the Realm of Glioblastoma Therapies.

I-Chung Chen, Hong-Yi Lin, Zheng-Yang Liu

|Sep 25, 2024
Syntheses of LSD1/HDAC Inhibitors with Demonstrated Efficacy against Colorectal Cancer: In Vitro and In Vivo Studies Including Patient-Derived Organoids.

Po-Yu Chou, Mei-Jung Lai, Kelvin K Tsai

|Jan 29, 2024
First-in-Class Dual EZH2-HSP90 Inhibitor Eliciting Striking Antiglioblastoma Activity In Vitro and In Vivo.

Sachin Sharma, Shao-An Wang, Wen-Bin Yang

|Sep 05, 2022
Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenal.

Kunal Nepali, Ram Sharma, Sachin Sharma

|Jul 05, 2022
Glioblastoma: Current Status, Emerging Targets, and Recent Advances.

Amandeep Thakur, Chetna Faujdar, Ram Sharma

Pageof 3

Frequent Collaborators

5 joint publications

Kunal Nepali

2 joint publications

Hsueh-Yun Lee

2 joint publications

Kai-Cheng Hsu

2 joint publications

Tsung-I Hsu